Pierre Danhier Selected Research

Pierre Danhier Research Topics

Disease

24	Neoplasms (Cancer) 04/2019 - 01/2010
7	Hypoxia (Hypoxemia) 01/2019 - 11/2010
4	Melanoma (Melanoma, Malignant) 04/2019 - 07/2011
3	Breast Neoplasms (Breast Cancer) 11/2018 - 03/2015
3	Neoplasm Metastasis (Metastasis) 01/2017 - 07/2011
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Ischemia 04/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Glioma (Gliomas) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Starvation 12/2016
1	Necrosis 04/2016
1	Prostatic Neoplasms (Prostate Cancer) 12/2015
1	Kidney Neoplasms (Kidney Cancer) 03/2014
1	Fibrosarcoma 05/2013
1	Experimental Melanoma 07/2011
1	Sarcoma (Soft Tissue Sarcoma) 07/2011
1	Hyperthermia 11/2010

Drug/Important Bio-Agent (IBA)

8	Oxygen (Dioxygen)IBA 04/2019 - 01/2012
6	LuciferasesIBA 01/2019 - 07/2011
3	ferric oxide (iron oxide)IBA 01/2018 - 03/2015
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 01/2012
3	Sorafenib (BAY 43-9006)FDA Link 04/2016 - 10/2012
2	Melanins (Melanin)IBA 04/2019 - 07/2011
2	tdTomatoIBA 01/2019 - 12/2015
2	enhanced green fluorescent proteinIBA 01/2019 - 12/2015
2	Contrast MediaIBA 01/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2015
2	Biomarkers (Surrogate Marker)IBA 08/2017 - 04/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 11/2010
2	MitoTEMPOIBA 01/2017 - 08/2014
2	Lactic Acid (Lactate)FDA LinkGeneric 12/2016 - 01/2012
2	Glucose (Dextrose)FDA LinkGeneric 12/2016 - 01/2016
2	Choline (Choline Chloride)IBA 04/2016 - 05/2013
2	MicellesIBA 02/2015 - 01/2012
1	Charcoal (Charbon)IBA 04/2019
1	SuspensionsIBA 04/2019
1	carbogenIBA 04/2019
1	IntegrinsIBA 01/2019
1	Red Fluorescent ProteinIBA 01/2019
1	AcriflavineIBA 11/2018
1	NanocapsulesIBA 11/2018
1	LipidsIBA 11/2018
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2018
1	IronIBA 06/2017
1	OxidesIBA 06/2017
1	AntioxidantsIBA 01/2017
1	Catechin (Z 7300)IBA 01/2017
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2017
1	mitoquinoneIBA 01/2017
1	Oxidants (Oxidizing Agents)IBA 01/2017
1	Lysine (L-Lysine)FDA Link 01/2017
1	lactate dehydrogenase 1 (LDH1)IBA 12/2016
1	NAD (NADH)IBA 12/2016
1	Pyruvic Acid (Pyruvate)IBA 12/2016
1	Antineoplastic Agents (Antineoplastics)IBA 04/2016
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 04/2016
1	Phosphorylcholine (Phosphocholine)IBA 04/2016
1	Small Interfering RNA (siRNA)IBA 04/2016
1	EnzymesIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2016
1	sodium bisulfide (NaHS)IBA 01/2016
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2016
1	rhodamine BIBA 03/2015
1	Liposomes (Liposome)IBA 02/2015
1	Superoxides (Superoxide)IBA 08/2014
1	alovudineIBA 05/2013
1	TrypsinIBA 01/2013
1	Collagenases (Collagenase)FDA Link 01/2013
1	A-factor (Streptomyces)IBA 10/2012
1	mirdametinibIBA 10/2012
1	Mitogen-Activated Protein KinasesIBA 10/2012
1	Monocarboxylic Acid TransportersIBA 01/2012
1	AnionsIBA 01/2012
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 11/2010
1	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2010
1	Xanthinol Niacinate (Xavin)IBA 01/2010

Therapy/Procedure

6	Radiotherapy 08/2017 - 11/2010
5	Therapeutics 01/2019 - 01/2010
2	Aftercare (After-Treatment) 02/2015 - 05/2013
1	Chemoradiotherapy 01/2020
1	Drug Therapy (Chemotherapy) 11/2010